Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation
Frontiers in Oncology · 22.05.2026 · 16
DOI: 10.3389/fonc.2026.1832473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 22.05.2026. Verfasst von Ruofan He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery 2 Section, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
RRN3 is a nucleolar protein required for ribosome biogenesis, but its role in cancer remains insufficiently defined. This study aimed to systematically evaluate the clinical relevance, molecular characteristics, immune-related features, and biological function of RRN3 across cancers, with a particular focus on gastric cancer (GC).
Methods
Public databases were used to analyze RRN3 expression, clinicopathological associations, survival outcomes, ROC curves, genomic alterations, epigenetic and epitranscriptomic features, immune-related characteristics, drug-response profiles, and co-expression networks. Functional enrichment analysis and a putative ceRNA regulatory network were further explored. Clinical tissue validation, in vitro rescue experiments, and in vivo xenograft assays were used to evaluate the involvement of RRN3 in GC progression.
Results
Pan-cancer analysis showed that RRN3 was upregulated in multiple tumor types, including GC, and that high RRN3 expression was associated with unfavorable overall survival in several cancers. In GC, RRN3 expression was associated with RNA methylation regulators, immune checkpoint genes, tumor mutation burden, microsatellite instability, immune cell infiltration, and drug-response-related signatures. Enrichment analyses suggested that RRN3-associated genes were mainly involved in nucleocytoplasmic transport, spliceosome function, mRNA surveillance, and ribosome biogenesis. Clinical validation showed that RRN3 was upregulated in GC tissues and associated with several clinicopathological features related to tumor progression. Functional experiments showed that RRN3 knockdown inhibited GC cell proliferation, colony formation, migration, and invasion, whereas RRN3 re-expression partly reversed these effects. In vivo xenograft experiments further supported the role of RRN3 in promoting tumor growth.
Discussion
These findings suggest that RRN3 is associated with GC progression and may represent a candidate molecule for further investigation in GC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery 2 Section, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
- Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.
- Department of Internal Medicine-Oncology, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, China.
- Department of Gastrointestinal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Urology, Fuzhou Hospital of Traditional Chinese Medicine Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China.
- Department of Gastrointestinal Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Zitieren
APA
He, R., Xing, Q., Liu, S., Lin, S., Lin, X., & Ye, J. (2026). Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1832473
Vancouver
He R, Xing Q, Liu S, Lin S, Lin X, Ye J. Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1832473
BibTeX
@article{He2026,
author = {He, Ruofan and Xing, Qingqing and Liu, Songyi and Lin, Shiwei and Lin, Xiang and Ye, Jianxin},
title = {Clinical significance and functional characterization of RRN3 in gastric cancer: insights from pan-cancer analysis and experimental validation},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1832473}
}
EUVIMED